Beg Faheemullah, Dadu Razvan T, Reardon Michael J, Little Stephen H, Kleiman Neal S, Barker Colin M
HOUSTON METHODIST DEBAKEY HEART & VASCULAR CENTER, HOUSTON METHODIST HOSPITAL, HOUSTON, TEXAS.
Methodist Debakey Cardiovasc J. 2019 Apr-Jun;15(2):149-151. doi: 10.14797/mdcj-15-2-149.
Patients with advanced valvular disease may be at high or prohibitive risk for surgical management. We describe a patient with previous mitral and tricuspid valve repair and recurrent admissions for New York Heart Association Class IV heart failure symptoms due to severe mitral stenosis and severe tricuspid regurgitation. Due to her comorbidities and two previous sternotomies, the patient was at high risk for surgery. We performed a simultaneous transfemoral mitral and tricuspid valve-in-ring implantation. This is the first report of its kind using a Sapien 3 valve (Edwards Lifesciences).
患有晚期瓣膜疾病的患者可能面临手术治疗的高风险或禁忌风险。我们描述了一名曾接受二尖瓣和三尖瓣修复术的患者,因严重二尖瓣狭窄和严重三尖瓣反流,因纽约心脏协会IV级心力衰竭症状反复入院。由于她的合并症和之前的两次胸骨切开术,该患者手术风险很高。我们同时经股动脉进行了二尖瓣和三尖瓣环内瓣膜植入术。这是首例使用Sapien 3瓣膜(爱德华生命科学公司)的此类报告。